Shulph Ink
Therapy Resistance in Prostate Cancer: Mechanisms and Insights
Therapy Resistance in Prostate Cancer: Mechanisms and Insights
💎 Earn 598 Points (£5.98) on this item.
YOU SAVE £14.40
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Bulk ordering. Want 15 or more copies? Get a personalised quote and bigger discounts. Learn more about bulk orders.
Couldn't load pickup availability
- More about Therapy Resistance in Prostate Cancer: Mechanisms and Insights
Therapy Resistance in Prostate Cancer: Mechanisms and Insights, Volume 20, highlights the main mechanisms responsible for therapy resistance in PCa, allowing researchers and clinicians to have a synopsis of current options and therapies that can be proposed to overcome resistance. Understanding the mechanisms responsible for chemotherapy resistance helps researchers delve deeper into the pathways behind this resistance and potentially discover new therapeutic targets for PCa.
Format: Hardback
Length: 340 pages
Publication date: 24 October 2023
Publisher: Elsevier Science Publishing Co Inc
Therapy resistance in prostate cancer (PCa) is a significant challenge that affects the effectiveness of treatment and contributes to poor survival rates. Understanding the mechanisms responsible for therapy resistance is crucial for developing new therapeutic strategies to overcome this obstacle. Volume 20 of Therapy Resistance in Prostate Cancer: Mechanisms and Insights provides a comprehensive overview of the main mechanisms that contribute to therapy resistance in PCa.
The first section of the book discusses the molecular mechanisms of therapy resistance in PCa. It highlights the role of DNA damage repair pathways, such as homologous recombination (HR) and non-homologous end joining (NHEJ), in the development of resistance to chemotherapy and targeted therapies. The authors explain how these pathways can be exploited to develop novel therapeutic approaches that target these mechanisms.
Another important mechanism of therapy resistance in PCa is the activation of signaling pathways that promote cell growth and survival. The book discusses the role of the PI3K/AKT/mTOR pathway, the MAPK pathway, and the androgen receptor (AR) in the development of resistance to chemotherapy and targeted therapies. The authors explain how these pathways can be targeted to develop novel therapeutic approaches that inhibit their activity.
The book also discusses the role of the tumor microenvironment in therapy resistance. The tumor microenvironment is a complex network of cells and molecules that surround the tumor and can influence its growth and survival. The authors explain how the tumor microenvironment can promote therapy resistance by creating a hostile environment for cancer cells and by providing them with nutrients and growth factors.
In addition to the molecular mechanisms of therapy resistance, the book also discusses the clinical implications of therapy resistance in PCa. It highlights the importance of early detection and screening for PCa to improve survival rates. The authors explain how early detection and screening can help identify patients who are at high risk of developing therapy resistance and who may benefit from targeted therapies.
The book also discusses the role of personalized medicine in therapy resistance in PCa. Personalized medicine involves tailoring treatment to the individual patient based on their genetic and molecular profile. The authors explain how personalized medicine can help improve survival rates and reduce the side effects of treatment.
Finally, the book discusses the future directions of therapy resistance in PCa. It highlights the need for continued research and development to develop new therapeutic strategies that can overcome therapy resistance. The authors suggest that future research should focus on developing targeted therapies that can specifically target the mechanisms of therapy resistance in PCa.
In conclusion, Therapy Resistance in Prostate Cancer: Mechanisms and Insights, Volume 20 is a comprehensive and valuable resource for researchers and clinicians who are interested in understanding the mechanisms responsible for therapy resistance in PCa. The book provides a synopsis of current options and therapies that can be proposed to overcome resistance and highlights the need for continued research and development to develop new therapeutic strategies that can improve survival rates and reduce the side effects of treatment.
Weight: 850g
Dimension: 197 x 245 x 24 (mm)
ISBN-13: 9780443160325
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
